Vice President, Clinical Development

Scorpion Therapeutics; United States; Hybrid; USD 250,000 - 380,000; Full time

Job summary

Scorpion Therapeutics seeks a Vice President of Clinical Development (Immunology & Inflammation) to lead antibody programs for IBD, directing cross-functional teams in protocol development, safety oversight, and data interpretation.

You will shape development plans, oversee global regulatory interactions, and mentor a clinical team, contributing to strategy and execution across Phase 2 and beyond.

Qualifications

• MD or equivalent with 7+ years in clinical development.
• Experience with antibody therapeutics and global regulatory processes.
• Leadership in mid-to-late-stage trials, esp. in IBD.
• Knowledge of trial design and regulatory standards.

Responsibilities

• Provide medical leadership for clinical trials, including protocol development, safety oversight, and data interpretation.
• Develop and refine clinical development plans.
• Lead global regulatory interactions and submissions.
• Collaborate cross-functionally with regulatory, biostatistics, clinical operations, and other teams.
• Mentor a clinical team and contribute to corporate strategy.

Skills

Clinical leadership

Trial design

Biostatistics

Regulatory submissions

Cross-functional leadership

Education

MD or equivalent

Job description

Role: Vice President, Clinical Development (Immunology & Inflammation), leading strategic and operational oversight of Spyre's antibody programs for IBD.

Responsibilities:

Provide medical leadership for clinical trials, including protocol development, safety oversight, and data interpretation; develop and refine clinical development plans; lead global regulatory interactions and submissions; collaborate cross-functionally with regulatory, biostatistics, clinical operations, and other teams; mentor a clinical team and contribute to corporate strategy.

Requirements:

MD or equivalent with 7+ years in clinical development, ideally within immunology, inflammation, or gastroenterology; extensive experience with antibody therapeutics and global regulatory processes; proven leadership in mid-to-late-stage trials, especially in IBD or immune-mediated disorders; strong knowledge of trial design, biostatistics, and regulatory standards.

High-Value:

antibody therapeutics, IBD (inflammatory bowel disease), clinical phases 2 and beyond, regulatory submissions (INDs, CTAs, BLAs, NDAs), global development.

Work Setup:

Remote with frequent in-person meetings; no specific travel requirements stated.